+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk factors for post transplant lymphoproliferative disorder ptld in renal transplant recipients



Risk factors for post transplant lymphoproliferative disorder ptld in renal transplant recipients



Journal of the American Society of Nephrology 2(3): 795




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033251625

Download citation: RISBibTeXText


Related references

Incidence and risk factors for post-transplant lymphoproliferative disorder among renal transplant recipients. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 564A, 2002

Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. American Journal of Transplantation 5(4 Pt 1): 775-780, 2005

Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplant. International Urology and Nephrology 40(2): 547-550, 2008

Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV) - seronegative adult liver transplant recipients. Transplant International 7(Suppl. S1): 235-237, 1994

Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients. Transplant International 7(Suppl. 1): S235, 1994

Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. American Journal of Transplantation 5(12): 2894-2900, 2005

Burkitt-like post-transplant lymphoproliferative disorder (PTLD) presenting with breast mass in a renal transplant recipient: a report of a rare case. Annals of Hematology 93(12): 2083-2085, 2014

Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients. Pediatric Nephrology 19(4): 365-368, 2004

The use of objective case ascertainment to identify risk factors for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder in pediatric liver transplant recipients. Hepatology 36(4 Part 2): 662A, 2002

Post transplant lymphoproliferative disorder ptld in renal allografts. Laboratory Investigation 60(1): 12A, 1989

Adenotonsillar hypertrophy and post-transplant lymphoproliferative disorder in pediatric renal transplant recipients. Pediatric Nephrology 19(4): 471-472, 2004

Post-transplant lymphoproliferative disorder in adult renal transplant recipients: survival and prognosis. Leukemia and Lymphoma 57(2): 299-305, 2016

European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment. Nephrology, Dialysis, Transplantation 17 Suppl 4(): 31-3, 35-6, 2002

Post-Transplant Lymphoproliferative Disorder (PTLD) Manifesting in the Oral Cavity of a 13-Year-Old Liver Transplant Recipient (LTx). Annals of Transplantation 20: 478-482, 2015

Long-term remission with rituximab in combination with CHOP in renal transplant recipients with post-transplant lymphoproliferative disorder. Journal of the American Society of Nephrology 14(Abstracts Issue): 918A, 2003